Financial Statements — GXAI
Balance Sheet
(in millions USD)| Metric | Q2
2026 | Q1
2026 | Q3
2025 | Q2
2025 | Q1
2025 | Q3
2024 | Q2
2024 | Q1
2024 | Q3
2023 | Q2
2023 | Q1
2023 |
|---|
| Cash & Equivalents | 1.09 | 1.51 | 0.91 | 1.72 | 2.57 | 5.23 | 2.37 | 3.31 | 0.76 | 1.69 | 2.21 |
| Short-term Investments | -- | -- | -- | -- | -- | -- | 2.10 | 2.09 | 3.57 | 3.53 | 3.51 |
| Accounts Receivable | 0.12 | 0.08 | 0.04 | 0.01 | 0.00 | -- | -- | 0.00 | -- | -- | -- |
| Total Current Assets | 11.89 | 12.16 | 13.42 | 14.50 | 15.17 | 6.93 | 4.89 | 5.77 | 4.42 | 5.33 | 5.89 |
| Property, Plant & Equipment | 0.07 | 0.09 | 0.10 | 0.09 | 0.08 | 0.06 | 0.06 | 0.07 | 0.02 | -- | -- |
| Intangible Assets | 0.63 | 0.67 | 0.76 | 0.81 | 0.85 | 0.13 | 0.14 | 0.15 | -- | 0.06 | 0.06 |
| Total Non-current Assets* | 5.57 | 3.66 | 0.87 | 0.90 | 0.94 | 0.19 | 0.20 | 0.22 | 0.02 | 0.00 | 0.06 |
| Total Assets | 17.46 | 15.82 | 14.29 | 15.40 | 16.10 | 7.12 | 5.09 | 5.98 | 4.44 | 5.33 | 5.94 |
| Accounts Payable | 0.33 | 0.23 | 0.21 | 0.25 | 0.32 | 0.33 | 0.30 | 0.39 | 0.18 | 0.18 | 0.13 |
| Total Current Liabilities | 1.13 | 0.57 | 0.45 | 0.51 | 0.50 | 0.40 | 0.39 | 0.51 | 0.20 | 0.28 | 0.15 |
| Total Non-current Liabilities* | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 1.13 | 0.57 | 0.45 | 0.51 | 0.50 | 0.40 | 0.39 | 0.51 | 0.20 | 0.28 | 0.15 |
| Retained Earnings | (14.63) | (14.87) | (11.74) | (10.74) | (9.99) | (7.97) | (7.10) | (6.29) | (4.58) | (3.72) | (2.97) |
| Total Stockholder Equity | 17.29 | 15.94 | 14.10 | 15.02 | 15.65 | 6.71 | 4.70 | 5.47 | 4.24 | 5.06 | 5.79 |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2026 | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 | Q1
2024 | Q4
2023 | Q3
2023 | Q2
2023 | Q1
2023 | Q4
2022 |
|---|
| Total Revenue | 2.46 | 1.81 | 1.24 | 0.50 | 0.17 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | -- | -- | -- | -- | -- |
| Research & Development | 0.51 | 0.45 | 0.26 | 0.27 | 0.24 | 0.22 | 0.31 | 0.25 | 0.25 | 0.18 | 0.29 | 0.26 | 0.27 | 0.10 | 0.22 |
| Selling, General & Admin | 3.82 | 3.91 | 2.21 | 1.54 | 0.91 | 1.19 | 0.59 | 0.66 | 0.61 | 0.86 | 0.55 | 0.62 | 0.45 | 1.44 | 0.11 |
| Total Operating Expenses | 4.32 | 4.36 | 2.47 | 1.81 | 1.15 | 1.42 | 0.90 | 0.91 | 0.85 | 1.04 | 0.83 | 0.87 | 0.77 | 1.54 | 0.32 |
| Operating Income | (1.86) | (2.55) | (1.23) | (1.31) | (0.98) | (1.39) | (0.90) | (0.91) | (0.85) | (1.04) | (0.83) | (0.87) | (0.77) | (1.54) | (0.32) |
| Net Income | 0.24 | (2.17) | (0.96) | (1.00) | (0.75) | (1.19) | (0.83) | (0.86) | (0.81) | (0.91) | (0.80) | (0.86) | (0.75) | (1.54) | (0.32) |
| Basic EPS | 0.02 | (0.25) | (0.13) | (0.14) | (0.11) | (0.17) | 0.32 | (0.61) | (0.72) | (0.91) | (3.73) | (0.07) | (0.06) | (0.14) | (0.04) |
| Diluted EPS | 0.02 | (0.25) | (0.13) | (0.14) | (0.11) | (0.17) | 0.32 | (0.61) | (0.72) | (0.91) | (3.73) | (0.07) | (0.06) | (0.14) | (0.04) |
Cash Flow Statement
(in millions USD)| Metric | Q2
2026 | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 | Q1
2024 | Q4
2023 | Q3
2023 | Q2
2023 | Q1
2023 |
|---|
| Operating Cash Flow | (1.09) | (2.49) | (0.73) | (1.11) | (0.72) | (1.30) | (0.77) | (0.67) | (0.74) | (1.10) | (0.67) | (0.87) | (0.50) | (0.93) |
| Investing Cash Flow | (0.34) | (2.15) | 0.66 | 0.30 | (0.14) | (10.53) | (0.77) | 0.70 | (0.20) | 0.35 | 0.98 | (0.02) | 0.00 | (3.49) |
| Financing Cash Flow | 1.00 | 5.32 | -- | -- | -- | -- | 10.71 | 2.84 | 0.00 | 3.04 | (0.05) | (0.03) | (0.02) | 5.96 |
